Christine Hann

Associate Professor

19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Christine Hann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Expression of Programmed Cell Death Ligand 1 and Associated Lymphocyte Infiltration in Olfactory Neuroblastoma

London, N. R., Rooper, L. M., Bishop, J. A., Xu, H., Bernhardt, L. J., Ishii, M., Hann, C. L., Taube, J. M., Izumchenko, E., Gaykalova, D. A. & Gallia, G. L., Jan 1 2020, (Accepted/In press) In : World neurosurgery.

Research output: Contribution to journalArticle

  • Dynamics of tumor and immune responses during immune checkpoint blockade in non–small cell lung cancer

    Anagnostou, V., Forde, P. M., White, J. R., Niknafs, N., Hruban, C., Naidoo, J., Marrone, K., Ashok Sivakumar, I. K., Bruhm, D. C., Rosner, S., Phallen, J., Leal, A., Adleff, V., Smith, K. N., Cottrell, T. R., Rhymee, L., Palsgrove, D. N., Hann, C. L., Levy, B., Feliciano, J. & 16 others, Georgiades, C., Verde, F., Illei, P., Li, Q. K., Gabrielson, E., Brock, M. V., Isbell, J. M., Sauter, J. L., Taube, J., Scharpf, R. B., Karchin, R., Pardoll, D. M., Chaft, J. E., Hellmann, M. D., Brahmer, J. R. & Velculescu, V. E., Jan 1 2019, In : Cancer Research. 79, 6, p. 1214-1225 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • Efficacy and safety of rovalpituzumab tesirine in third-line and beyond patients with DLL3-expressing, relapsed/refractory small-cell lung cancer: Results from the phase II TrINITY study

    Morgensztern, D., Besse, B., Greillier, L., Santana-Davila, R., Ready, N., Hann, C. L., Glisson, B. S., Farago, A. F., Dowlati, A., Rudin, C. M., Le Moulec, S., Lally, S., Yalamanchili, S., Wolf, J., Govindan, R. & Carbone, D. P., Dec 1 2019, In : Clinical Cancer Research. 25, 23, p. 6958-6966 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • Lung cancer and family-centered concerns

    Feliciano, J., Chang, A., Venkatraman, D., Brooks, S., Zagaja, C., Ettinger, D. S., Hann, C., Naidoo, J., Voong, K., Hales, R., Turner, M., Peterson, V. & Bodurtha, J. N., Jan 1 2019, In : Supportive Care in Cancer.

    Research output: Contribution to journalArticle

  • Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort

    Ready, N. E., Ott, P. A., Hellmann, M. D., Zugazagoitia, J., Hann, C. L., de Braud, F., Antonia, S. J., Ascierto, P. A., Moreno, V., Atmaca, A., Salvagni, S., Taylor, M., Amin, A., Camidge, D. R., Horn, L., Calvo, E., Li, A., Lin, W. H., Callahan, M. K. & Spigel, D. R., Jan 1 2019, (Accepted/In press) In : Journal of Thoracic Oncology.

    Research output: Contribution to journalArticle

    Open Access